A client arrives to the healthcare setting currently taking atorvastatin (Lipitor) daily. Which assessment finding associated with atorvastatin (Lipitor) would need immediate reporting to the healthcare provider?
bradycardia
elevated HDL cholesterol
migraine headache
dark-red urine
The Correct Answer is D
A. Bradycardia is not a direct side effect of atorvastatin and may require further context for concern.
B. Elevated HDL cholesterol is a positive outcome of atorvastatin therapy and does not require reporting.
C. A migraine headache is not typically a direct side effect of atorvastatin but could warrant discussion if it affects the client's overall well-being.
D. Dark-red urine may indicate potential muscle breakdown (rhabdomyolysis) associated with atorvastatin and should be reported immediately due to the risk of kidney damage.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is {"dropdown-group-1":"A","dropdown-group-2":"D"}
Explanation
aPTT (Activated Partial Thromboplastin Time) is the primary lab test used to monitor the effectiveness of unfractionated heparin therapy. Heparin works by activating antithrombin III, which inhibits thrombin and factor Xa, thus prolonging the aPTT. Monitoring aPTT helps ensure that the heparin dose is therapeutic and reduces the risk of bleeding.
PT-INR (Prothrombin Time - International Normalized Ratio) is used to monitor patients on warfarin therapy. Warfarin inhibits vitamin K-dependent clotting factors, which affects the prothrombin time (PT). The INR standardizes PT results, allowing for consistent monitoring of anticoagulation status. It is critical to maintain the INR within the therapeutic range to balance the risk of thrombosis against the risk of bleeding.
Correct Answer is C
Explanation
A. Doxazosin is an alpha-1 blocker that can be used for hypertension but is not a first-line option.
B. Carvedilol is a beta-blocker used in heart failure and post-MI but is not the first choice for initial hypertension treatment.
C. Lisinopril, an ACE inhibitor, is widely recognized as a first-line treatment for hypertension due to its effectiveness and favorable side effect profile.
D. Clonidine is generally not considered a first-line treatment for hypertension due to potential side effects and the availability of more effective alternatives.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
